Zotefoams plc Logo

Zotefoams plc

ZTF.L

(2.5)
Stock Price

346,00 GBp

5.36% ROA

8.42% ROE

19.88x PER

Market Cap.

193.494.108,00 GBp

42.07% DER

1.83% Yield

7.45% NPM

Zotefoams plc Stock Analysis

Zotefoams plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Zotefoams plc Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (35%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

4 ROE

ROE in an average range (9.65%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (6.15%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 PBV

The stock's PBV ratio (1.41x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

7 Dividend Growth

With a history of consistent dividend increases over the last three years, the company has proven to be a reliable choice for investors seeking reliable income.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Buffet Intrinsic Value

The company's stock appears overvalued (49) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Zotefoams plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Zotefoams plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Zotefoams plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Zotefoams plc Revenue
Year Revenue Growth
1992 12.909.000
1993 14.380.000 10.23%
1994 17.603.000 18.31%
1995 22.761.000 22.66%
1996 21.390.000 -6.41%
1997 24.365.000 12.21%
1998 24.199.000 -0.69%
1999 22.426.000 -7.91%
2000 20.828.000 -7.67%
2001 22.975.000 9.34%
2002 23.468.000 2.1%
2003 23.504.000 0.15%
2004 25.176.000 6.64%
2005 27.975.000 10.01%
2006 30.052.000 6.91%
2007 31.606.000 4.92%
2008 34.781.000 9.13%
2009 31.816.000 -9.32%
2010 39.879.000 20.22%
2011 44.208.000 9.79%
2012 47.188.000 6.32%
2013 44.634.000 -5.72%
2014 48.945.000 8.81%
2015 53.869.000 9.14%
2016 57.376.000 6.11%
2017 70.146.000 18.2%
2018 81.037.000 13.44%
2019 80.860.000 -0.22%
2019 80.860.000 0%
2020 82.652.000 2.17%
2021 100.750.000 17.96%
2022 127.369.000 20.9%
2023 126.975.000 -0.31%
2024 284.240.000 55.33%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Zotefoams plc Research and Development Expenses
Year Research and Development Expenses Growth
1992 0
1993 0 0%
1994 261.000 100%
1995 290.000 10%
1996 308.000 5.84%
1997 375.000 17.87%
1998 389.000 3.6%
1999 388.000 -0.26%
2000 529.000 26.65%
2001 622.000 14.95%
2002 492.000 -26.42%
2003 635.000 22.52%
2004 734.000 13.49%
2005 776.000 5.41%
2006 924.000 16.02%
2007 803.000 -15.07%
2008 731.000 -9.85%
2009 776.000 5.8%
2010 875.000 11.31%
2011 897.000 2.45%
2012 0 0%
2013 1.287.000 100%
2014 1.388.000 7.28%
2015 1.084.000 -28.04%
2016 1.151.000 5.82%
2017 1.529.000 24.72%
2018 1.465.000 -4.37%
2019 0 0%
2019 1.236.000 100%
2020 1.014.000 -21.89%
2021 179.000 -466.48%
2022 -405.000 144.2%
2023 -1.423.000 71.54%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Zotefoams plc General and Administrative Expenses
Year General and Administrative Expenses Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 229.000 100%
2003 163.000 -40.49%
2004 241.000 32.37%
2005 -274.000 187.96%
2006 -346.000 20.81%
2007 -154.000 -124.68%
2008 -463.000 66.74%
2009 -878.000 47.27%
2010 -692.000 -26.88%
2011 -131.000 -428.24%
2012 4.329.000 103.03%
2013 3.868.000 -11.92%
2014 3.829.000 -1.02%
2015 5.714.000 32.99%
2016 7.607.000 24.88%
2017 10.359.000 26.57%
2018 10.236.000 -1.2%
2019 11.481.000 10.84%
2019 11.462.000 -0.17%
2020 11.854.000 3.31%
2021 11.045.000 -7.32%
2022 16.741.000 34.02%
2023 17.993.000 6.96%
2024 37.232.000 51.67%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Zotefoams plc EBITDA
Year EBITDA Growth
1992 3.498.000
1993 4.954.000 29.39%
1994 6.591.000 24.84%
1995 8.750.000 24.67%
1996 8.604.000 -1.7%
1997 9.805.000 12.25%
1998 9.187.000 -6.73%
1999 7.884.000 -16.53%
2000 5.475.000 -44%
2001 -724.000 856.22%
2002 8.708.000 108.31%
2003 4.270.000 -103.93%
2004 5.746.000 25.69%
2005 5.371.000 -6.98%
2006 6.095.000 11.88%
2007 6.632.000 8.1%
2008 6.946.000 4.52%
2009 6.802.000 -2.12%
2010 8.200.000 17.05%
2011 8.808.000 6.9%
2012 10.371.000 15.07%
2013 7.479.000 -38.67%
2014 8.887.000 15.84%
2015 9.294.000 4.38%
2016 10.713.000 13.25%
2017 12.303.000 12.92%
2018 16.132.000 23.74%
2019 16.042.000 -0.56%
2019 16.352.000 1.9%
2020 16.195.000 -0.97%
2021 13.391.000 -20.94%
2022 27.167.000 50.71%
2023 23.460.000 -15.8%
2024 53.648.000 56.27%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Zotefoams plc Gross Profit
Year Gross Profit Growth
1992 12.909.000
1993 14.380.000 10.23%
1994 17.603.000 18.31%
1995 22.761.000 22.66%
1996 21.390.000 -6.41%
1997 24.365.000 12.21%
1998 11.051.000 -120.48%
1999 9.583.000 -15.32%
2000 6.563.000 -46.02%
2001 4.141.000 -58.49%
2002 6.226.000 33.49%
2003 5.026.000 -23.88%
2004 5.569.000 9.75%
2005 6.335.000 12.09%
2006 7.795.000 18.73%
2007 8.571.000 9.05%
2008 10.123.000 15.33%
2009 9.563.000 -5.86%
2010 11.449.000 16.47%
2011 12.584.000 9.02%
2012 13.667.000 7.92%
2013 11.619.000 -17.63%
2014 12.842.000 9.52%
2015 17.267.000 25.63%
2016 20.335.000 15.09%
2017 25.487.000 20.21%
2018 29.003.000 12.12%
2019 28.590.000 -1.44%
2019 28.590.000 0%
2020 27.778.000 -2.92%
2021 26.566.000 -4.56%
2022 38.730.000 31.41%
2023 41.055.000 5.66%
2024 94.280.000 56.45%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Zotefoams plc Net Profit
Year Net Profit Growth
1992 1.949.000
1993 1.835.000 -6.21%
1994 3.110.000 41%
1995 4.684.000 33.6%
1996 4.576.000 -2.36%
1997 5.709.000 19.85%
1998 5.651.000 -1.03%
1999 4.069.000 -38.88%
2000 1.751.000 -132.38%
2001 3.269.000 46.44%
2002 6.039.000 45.87%
2003 736.000 -720.52%
2004 1.170.000 37.09%
2005 2.427.000 51.79%
2006 1.239.000 -95.88%
2007 2.918.000 57.54%
2008 3.006.000 2.93%
2009 2.164.000 -38.91%
2010 4.352.000 50.28%
2011 4.497.000 3.22%
2012 4.728.000 4.89%
2013 3.161.000 -49.57%
2014 3.336.000 5.25%
2015 4.824.000 30.85%
2016 5.795.000 16.76%
2017 6.008.000 3.55%
2018 7.852.000 23.48%
2019 8.217.000 4.44%
2019 8.217.000 0%
2020 7.163.000 -14.71%
2021 4.376.000 -63.69%
2022 10.006.000 56.27%
2023 9.242.000 -8.27%
2024 25.132.000 63.23%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Zotefoams plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Zotefoams plc Free Cashflow
Year Free Cashflow Growth
1992 3.081.000
1993 2.758.000 -11.71%
1994 1.845.000 -49.49%
1995 -1.679.000 209.89%
1996 -852.000 -97.07%
1997 1.899.000 144.87%
1998 303.000 -526.73%
1999 943.000 67.87%
2000 -4.289.000 121.99%
2001 -8.811.000 51.32%
2002 2.312.000 481.1%
2003 -2.075.000 211.42%
2004 3.156.000 165.75%
2005 2.127.000 -48.38%
2006 1.126.000 -88.9%
2007 1.385.000 18.7%
2008 3.434.000 59.67%
2009 2.377.000 -44.47%
2010 3.489.000 31.87%
2011 2.235.000 -56.11%
2012 1.512.000 -47.82%
2013 1.455.000 -3.92%
2014 -913.000 259.36%
2015 -1.150.000 20.61%
2016 -6.970.000 83.5%
2017 -2.653.000 -162.72%
2018 -11.335.000 76.59%
2019 -3.759.500 -201.5%
2019 -15.921.000 76.39%
2020 -1.851.000 -760.13%
2021 3.826.000 148.38%
2022 14.032.000 72.73%
2023 -511.000 2845.99%
2024 -36.000 -1319.44%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Zotefoams plc Operating Cashflow
Year Operating Cashflow Growth
1992 3.627.000
1993 3.263.000 -11.16%
1994 2.835.000 -15.1%
1995 4.130.000 31.36%
1996 5.015.000 17.65%
1997 5.228.000 4.07%
1998 4.682.000 -11.66%
1999 3.569.000 -31.19%
2000 1.850.000 -92.92%
2001 -2.746.000 167.37%
2002 7.509.000 136.57%
2003 -461.000 1728.85%
2004 4.487.000 110.27%
2005 3.197.000 -40.35%
2006 3.767.000 15.13%
2007 4.077.000 7.6%
2008 5.004.000 18.53%
2009 5.808.000 13.84%
2010 6.157.000 5.67%
2011 4.979.000 -23.66%
2012 5.258.000 5.31%
2013 5.596.000 6.04%
2014 5.054.000 -10.72%
2015 7.533.000 32.91%
2016 5.170.000 -45.71%
2017 8.732.000 40.79%
2018 4.492.000 -94.39%
2019 2.337.250 -92.19%
2019 8.466.000 72.39%
2020 10.858.000 22.03%
2021 10.897.000 0.36%
2022 21.124.000 48.41%
2023 7.972.000 -164.98%
2024 6.084.000 -31.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Zotefoams plc Capital Expenditure
Year Capital Expenditure Growth
1992 546.000
1993 505.000 -8.12%
1994 990.000 48.99%
1995 5.809.000 82.96%
1996 5.867.000 0.99%
1997 3.329.000 -76.24%
1998 4.379.000 23.98%
1999 2.626.000 -66.76%
2000 6.139.000 57.22%
2001 6.065.000 -1.22%
2002 5.197.000 -16.7%
2003 1.614.000 -222%
2004 1.331.000 -21.26%
2005 1.070.000 -24.39%
2006 2.641.000 59.49%
2007 2.692.000 1.89%
2008 1.570.000 -71.46%
2009 3.431.000 54.24%
2010 2.668.000 -28.6%
2011 2.744.000 2.77%
2012 3.746.000 26.75%
2013 4.141.000 9.54%
2014 5.967.000 30.6%
2015 8.683.000 31.28%
2016 12.140.000 28.48%
2017 11.385.000 -6.63%
2018 15.827.000 28.07%
2019 6.096.750 -159.6%
2019 24.387.000 75%
2020 12.709.000 -91.89%
2021 7.071.000 -79.73%
2022 7.092.000 0.3%
2023 8.483.000 16.4%
2024 6.120.000 -38.61%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Zotefoams plc Equity
Year Equity Growth
1992 9.632.000
1993 10.238.000 5.92%
1994 11.886.000 13.87%
1995 19.394.000 38.71%
1996 21.718.000 10.7%
1997 24.649.000 11.89%
1998 27.693.000 10.99%
1999 29.059.000 4.7%
2000 28.143.000 -3.25%
2001 29.001.000 2.96%
2002 31.591.000 8.2%
2003 29.836.000 -5.88%
2004 24.053.000 -24.04%
2005 25.622.000 6.12%
2006 24.838.000 -3.16%
2007 26.666.000 6.86%
2008 29.221.000 8.74%
2009 27.682.000 -5.56%
2010 35.014.000 20.94%
2011 35.252.000 0.68%
2012 35.690.000 1.23%
2013 39.014.000 8.52%
2014 47.234.000 17.4%
2015 51.120.000 7.6%
2016 56.383.000 9.33%
2017 59.090.000 4.58%
2018 85.081.000 30.55%
2019 89.640.000 5.09%
2020 94.376.000 5.02%
2021 97.775.000 3.48%
2022 109.538.000 10.74%
2023 115.763.000 5.38%
2023 112.957.000 -2.48%
2024 120.264.000 6.08%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Zotefoams plc Assets
Year Assets Growth
1992 21.318.000
1993 22.657.000 5.91%
1994 25.022.000 9.45%
1995 29.961.000 16.48%
1996 31.667.000 5.39%
1997 33.784.000 6.27%
1998 36.748.000 8.07%
1999 38.381.000 4.25%
2000 39.667.000 3.24%
2001 43.548.000 8.91%
2002 44.142.000 1.35%
2003 41.658.000 -5.96%
2004 38.894.000 -7.11%
2005 39.043.000 0.38%
2006 37.147.000 -5.1%
2007 38.463.000 3.42%
2008 42.219.000 8.9%
2009 42.926.000 1.65%
2010 49.847.000 13.88%
2011 51.515.000 3.24%
2012 53.527.000 3.76%
2013 53.693.000 0.31%
2014 63.371.000 15.27%
2015 76.206.000 16.84%
2016 91.477.000 16.69%
2017 100.264.000 8.76%
2018 126.901.000 20.99%
2019 144.406.000 12.12%
2020 158.225.000 8.73%
2021 159.376.000 0.72%
2022 170.359.000 6.45%
2023 175.609.000 2.99%
2023 172.375.000 -1.88%
2024 196.555.000 12.3%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Zotefoams plc Liabilities
Year Liabilities Growth
1992 11.584.000
1993 12.327.000 6.03%
1994 13.039.000 5.46%
1995 10.567.000 -23.39%
1996 9.949.000 -6.21%
1997 9.135.000 -8.91%
1998 9.055.000 -0.88%
1999 9.322.000 2.86%
2000 11.524.000 19.11%
2001 14.547.000 20.78%
2002 12.551.000 -15.9%
2003 11.822.000 -6.17%
2004 14.841.000 20.34%
2005 13.421.000 -10.58%
2006 12.309.000 -9.03%
2007 11.797.000 -4.34%
2008 12.998.000 9.24%
2009 15.244.000 14.73%
2010 14.833.000 -2.77%
2011 16.263.000 8.79%
2012 17.837.000 8.82%
2013 14.679.000 -21.51%
2014 16.137.000 9.04%
2015 25.086.000 35.67%
2016 35.094.000 28.52%
2017 41.174.000 14.77%
2018 41.820.000 1.54%
2019 54.766.000 23.64%
2020 63.849.000 14.23%
2021 61.601.000 -3.65%
2022 60.821.000 -1.28%
2023 59.846.000 -1.63%
2023 59.418.000 -0.72%
2024 76.291.000 22.12%

Zotefoams plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.68
Net Income per Share
0.2
Price to Earning Ratio
19.88x
Price To Sales Ratio
1.45x
POCF Ratio
19.64
PFCF Ratio
-98.47
Price to Book Ratio
1.64
EV to Sales
1.77
EV Over EBITDA
9.9
EV to Operating CashFlow
23.48
EV to FreeCashFlow
-120.17
Earnings Yield
0.05
FreeCashFlow Yield
-0.01
Market Cap
0,19 Bil.
Enterprise Value
0,24 Bil.
Graham Number
3.3
Graham NetNet
-0.45

Income Statement Metrics

Net Income per Share
0.2
Income Quality
1.01
ROE
0.08
Return On Assets
0.05
Return On Capital Employed
0.12
Net Income per EBT
0.72
EBT Per Ebit
0.86
Ebit per Revenue
0.12
Effective Tax Rate
0.28

Margins

Sales, General, & Administrative to Revenue
0.14
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.33
Operating Profit Margin
0.12
Pretax Profit Margin
0.1
Net Profit Margin
0.07

Dividends

Dividend Yield
0.02
Dividend Yield %
1.83
Payout Ratio
0.35
Dividend Per Share
0.07

Operating Metrics

Operating Cashflow per Share
0.2
Free CashFlow per Share
-0.04
Capex to Operating CashFlow
1.2
Capex to Revenue
0.09
Capex to Depreciation
1.46
Return on Invested Capital
0.07
Return on Tangible Assets
0.05
Days Sales Outstanding
99.36
Days Payables Outstanding
60.49
Days of Inventory on Hand
149.92
Receivables Turnover
3.67
Payables Turnover
6.03
Inventory Turnover
2.43
Capex per Share
0.24

Balance Sheet

Cash per Share
0,16
Book Value per Share
2,42
Tangible Book Value per Share
2.19
Shareholders Equity per Share
2.42
Interest Debt per Share
1.07
Debt to Equity
0.42
Debt to Assets
0.26
Net Debt to EBITDA
1.79
Current Ratio
1.3
Tangible Asset Value
0,11 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
133179000
Working Capital
0,02 Bil.
Intangibles to Total Assets
0.06
Average Receivables
0,03 Bil.
Average Payables
0,01 Bil.
Average Inventory
34437000
Debt to Market Cap
0.26

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Zotefoams plc Dividends
Year Dividends Growth
1995 2
1996 6 80%
1997 6 16.67%
1998 7 0%
1999 7 14.29%
2000 8 0%
2001 8 0%
2002 8 0%
2003 8 0%
2004 4 -133.33%
2005 5 25%
2006 5 0%
2007 5 0%
2008 5 0%
2009 5 0%
2010 5 0%
2011 5 0%
2012 5 20%
2013 5 0%
2014 5 0%
2015 6 0%
2016 6 0%
2017 6 0%
2018 6 0%
2019 6 16.67%
2020 2 -200%
2021 6 66.67%
2022 7 0%
2023 7 0%
2024 7 14.29%

Zotefoams plc Profile

About Zotefoams plc

Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, Continental Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand. The company also provides T-FIT, a clean insulation system that is used in the pharmaceutical, biotech, and semiconductor cleanroom industries. In addition, it owns and licenses patented MuCell microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was founded in 1921 and is headquartered in Croydon, the United Kingdom.

CEO
Mr. Ronan Michael Cox
Employee
632
Address
675 Mitcham Road
Croydon, CR9 3AL

Zotefoams plc Executives & BODs

Zotefoams plc Executives & BODs
# Name Age
1 Mr. David Burns Stirling B.Sc., BSC CA, C.A., M.B.A., M.Sc.
Executive Officer
70
2 Mr. Ronan Michael Cox
Group Chief Executive Officer & Executive Director
70
3 Lydia Florinette Gabrielle Harratt
Company Secretary
70
4 Mr. Gary Christopher McGrath
Group Chief Financial Officer & Executive Director
70
5 Mr. Benito Sala
Managing Director of Europe, UK
70

Zotefoams plc Competitors

Treatt plc Logo
Treatt plc

TET.L

(1.8)
Porvair plc Logo
Porvair plc

PRV.L

(3.5)
Trifast plc Logo
Trifast plc

TRI.L

(2.2)
XP Power Limited Logo
XP Power Limited

XPP.L

(0.8)
Victrex plc Logo
Victrex plc

VCT.L

(1.8)